MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-PB-20-0011753
Innovexia Life Sciences Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹7.33 Cr
▼ 2% YoY
Net profit · FY 2024
₹11.87 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹64.41 Lakh
EBITDA margin 8.8%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹5.58 Cr
Satisfied ₹1.18 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
24
Provident fund records
About Innovexia Life Sciences Private Limited
Data last updated:
Innovexia Life Sciences Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24100CH2011PTC033197. Its GSTIN is 03AACCI6979F2ZF (Punjab). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Sandeep Khajuria and Rohit Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # 115 GF Bungalow Sector – 46/A, Chandigarh, India – 160047.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.33 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹11.87 Lakh (net margin 1.6%) and EBITDA of ₹64.41 Lakh (EBITDA margin 8.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 2% over five years.
The company has about 24 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Innovexia Life Sciences. As per MCA filings, the company has open charges of ₹5.58 Cr and satisfied charges of ₹1.18 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in August 2022.
Innovexia Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0011753). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innovexia.com.
Company details
CIN U24100CH2011PTC033197
Registration Number 033197
Incorporation Date 25 August 2011
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-PB-20-0011753
CIN history
Innovexia Life Sciences has one previous CIN (Corporate Identification Number): U52310CH2011PTC033197. The current CIN is U24100CH2011PTC033197, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100CH2011PTC033197 | Current |
| U52310CH2011PTC033197 | Previous |
Recognitions & Rankings of Innovexia Life Sciences
Contact details
Innovexia Life Sciences Private Limited's registered office is in Chandigarh, Chandigarh. Its website is innovexia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address# 115 GF Bungalow Sector – 46/A, Chandigarh, India – 160047
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Innovexia Life Sciences Private Limited, buy the company report.
Comprehensive company report
Innovexia Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Innovexia Life Sciences operates one associated brand: Innovexia Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Operates as a pharmaceutical franchise company offering a range of products to customers. | innovexia.com |
Financials of Innovexia Life Sciences Private Limited
FY 2025 filings availableInnovexia Life Sciences Private Limited reported revenue of ₹7.33 Cr (down 2% YoY) for FY 2024.
Revenue · FY 2024
₹7.33 Cr ▼ 2%
Net profit · FY 2024
₹11.87 Lakh margin 1.6%
EBITDA · FY 2024
₹64.41 Lakh margin 8.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 3%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 45%
3 years · compounded
▲ 22%
5 years · compounded
▲ 23%
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹7.33 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹64.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.87 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innovexia Life Sciences Private Limited, buy the company report.
Board of directors of Innovexia Life Sciences Private Limited
Innovexia Life Sciences has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Khajuria | Director | 31 Jul 2020 | 6 Years 2 Months | Current |
| Rohit Sharma Also directs: Medrix Labs Private Limited | Director | 25 Aug 2011 | 15 Years 2 Months | Current |
| Reecha Sharma | Director | 25 Aug 2011 | 15 Years 2 Months | Current |
Auditor
Innovexia Life Sciences Private Limited is audited by Amit K Sharma & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Amit K Sharma & Associates | FY 2024 | 021287N |
Shareholding
The shareholding of Innovexia Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Innovexia Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.58 Cr
Satisfied charges
₹1.18 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Feb 2025 | 101055422 | Others | ₹5.58 Cr | Open | |
| 24 Feb 2018 | 100161069 | Others | ₹1.03 Cr | Satisfied | |
| 18 Sep 2012 | 10379786 | Others | ₹14.5 Lakh | Satisfied |
To see the full charge records of Innovexia Life Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Innovexia Life Sciences Private Limited has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in August 2022.
Total deals
2
Rights issue
1
Secondary share transfer
1
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2022 | Rights issue | ₹45 Lakh | Investors: 2 individuals |
| Jul 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Innovexia Life Sciences Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Glaxosmithkline Pharmaceuticals Limited | Pending |
To see the full case history of Innovexia Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innovexia Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Innovexia Life Sciences has 4 GST registrations: 2 active and 2 cancelled or inactive.
Total GSTINs
4
Active
2
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AACCI6979F2ZF | Punjab | Active | 23 May 2018 |
| 01AACCI6979F1ZK | Jammu and Kashmir | Active | 08 Feb 2022 |
To see the full GST registrations and return filing status of Innovexia Life Sciences Private Limited, buy the company report.
Recent activity
Innovexia Life Sciences Private Limited has 4 board changes on record since 2011: 3 appointments and 1 cessation. The latest: Rohit Sharma ceased to be Director on 01 Aug 2020.
AGM
Innovexia Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Innovexia Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Others amounted to Rs. 558.00 Lakh with Charge ID 101055422 was registered on 10 Feb 2025.
Charges
A charge registered on 24 Feb 2018 via Charge ID 100161069 with Others was fully satisfied on 30 Oct 2022.
Charges
A charge registered on 18 Sep 2012 via Charge ID 10379786 with Others was fully satisfied on 06 Aug 2022.
Charges
A charge with Others of Rs. 103.00 Lakh registered on 24 Feb 2018 with Charge ID 100161069 was modified on 26 Feb 2021.
Ceased
Rohit Sharma ceased to be Director.
Appointed
Sandeep Khajuria was appointed as Director.
Charges
A charge with Others of Rs. 14.50 Lakh registered on 18 Sep 2012 with Charge ID 10379786 was modified on 23 May 2019.
Charges
A charge with Others amounted to Rs. 103.00 Lakh with Charge ID 100161069 was registered on 24 Feb 2018.
Charges
A charge with Others amounted to Rs. 14.50 Lakh with Charge ID 10379786 was registered on 18 Sep 2012.
Appointed
Reecha Sharma was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Innovexia Life Sciences is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 August 2011 (15+ years old) and is registered under CIN U24100CH2011PTC033197.
Innovexia Life Sciences has 3 current directors:
- Sandeep Khajuria - Director
- Rohit Sharma - Director
- Reecha Sharma - Director
The latest financial statements of Innovexia Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Innovexia Life Sciences is 03AACCI6979F2ZF, registered in Punjab. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 01AACCI6979F1ZK (Jammu and Kashmir).
The CIN (Corporate Identification Number) of Innovexia Life Sciences is U24100CH2011PTC033197. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innovexia Life Sciences has 1 court case on record: 1 filed against it. 1 is pending.
Innovexia Life Sciences was incorporated on 25 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chandigarh.
Innovexia Life Sciences has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in August 2022.
Rohit Sharma ceased to be Director on 01 Aug 2020. Sandeep Khajuria was appointed as Director on 31 Jul 2020. Reecha Sharma was appointed as Director on 25 Aug 2011. Innovexia Life Sciences has 4 board changes on record in total.
Yes, Innovexia Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-PB-20-0011753).